RIGI and COVID-19: We have recently described autoantibodies directed towards antiviral signaling proteins (e.g., MDA5 and RIG-I) in a cohort of patients affected by mild COVID-19; however, none of the aforementioned patients developed any feature suggestive of systemic autoimmune disease (28).